284 related articles for article (PubMed ID: 14510246)
1. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.
Bernard L; Vaudaux P; Vuagnat A; Stern R; Rohner P; Pittet D; Schrenzel J; Hoffmeyer P;
Infect Control Hosp Epidemiol; 2003 Sep; 24(9):650-4. PubMed ID: 14510246
[TBL] [Abstract][Full Text] [Related]
2. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
3. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.
Solís A; Brown D; Hughes J; Van Saene HK; Heaf DP
Pediatr Pulmonol; 2003 Sep; 36(3):189-95. PubMed ID: 12910579
[TBL] [Abstract][Full Text] [Related]
5. Topical oropharyngeal vancomycin to control methicillin-resistant Staphylococcus aureus lower airway infection in ventilated patients.
Silvestri L; Solidoro A; Milanese M; Van Saene HK; Fontana F; Gregori D; Gullo A
Minerva Anestesiol; 2010 Mar; 76(3):193-202. PubMed ID: 20203547
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
7. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
8. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
[TBL] [Abstract][Full Text] [Related]
9. MRSA--the tip of the iceberg.
Appelbaum PC
Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
[TBL] [Abstract][Full Text] [Related]
10. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients.
Silvestri L; Milanese M; Oblach L; Fontana F; Gregori D; Guerra R; van Saene HK
Am J Infect Control; 2002 Nov; 30(7):391-9. PubMed ID: 12410215
[TBL] [Abstract][Full Text] [Related]
11. Intermediate vancomycin susceptibility in a community-associated MRSA clone.
Graber CJ; Wong MK; Carleton HA; Perdreau-Remington F; Haller BL; Chambers HF
Emerg Infect Dis; 2007 Mar; 13(3):491-3. PubMed ID: 17552110
[TBL] [Abstract][Full Text] [Related]
12. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
13. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
Alp E; Gozukucuk S; Canoz O; Kirmaci B; Doganay M
BMC Infect Dis; 2004 Oct; 4():43. PubMed ID: 15491501
[TBL] [Abstract][Full Text] [Related]
15. Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit.
Thorburn K; Taylor N; Saladi SM; van Saene HK
Clin Microbiol Infect; 2006 Jan; 12(1):35-42. PubMed ID: 16460544
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Sakoulas G; Moellering RC; Eliopoulos GM
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
[TBL] [Abstract][Full Text] [Related]
17. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
18. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.
Moise PA; Sakoulas G; Forrest A; Schentag JJ
Antimicrob Agents Chemother; 2007 Jul; 51(7):2582-6. PubMed ID: 17452488
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]